Concepedia

Kunika Kikumori

KK

Statistics

Publications

2

Citations

29

H-Index

2

Active since

2022

Affiliations

Daiichi-Sankyo (Japan)(Current)

Kunika Kikumori is an author at Daiichi-Sankyo (Japan) specializing in cancer immunotherapy, human epidermal growth factor receptor 2-targeted therapy, and metastatic breast cancer treatment.

Publications per year

2022–2024

2

Publications

2

Effect of Trastuzumab Deruxtecan on <scp>QT</scp>/<scp>QTc</scp> Interval and Pharmacokinetics in <scp>HER2‐Positive</scp> or <scp>HER2‐Low</scp> Metastatic/Unresectable Breast Cancer

Akihiko Shimomura, Toshimi Takano, Shunji Takahashi et al. · Clinical Pharmacology & Therapeutics · 2022 · 15 citations · Full text

, , +17

A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled 14-Week Study of Mirogabalin in Chinese Patients with Diabetic Peripheral Neuropathic Pain

Xiaohui Guo, Yang Yu, Yongbo Zhang et al. · Pain and Therapy · 2024 · 14 citations · Full text

, , +17

1–2 of 2